---
title: "TG Therapeutics Flashes An Early Buy Signal — What Drove The Bullish Jump"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288635239.md"
description: "TG Therapeutics stock surged following news that its subcutaneous injection of Briumvi demonstrated safety comparable to intravenous administration. This development triggered an early buy signal and a bullish jump in the biotech company's shares, as investors reacted positively to the potential for increased interest and growth opportunities associated with the new route of administration."
datetime: "2026-06-03T21:46:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288635239.md)
  - [en](https://longbridge.com/en/news/288635239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288635239.md)
---

# TG Therapeutics Flashes An Early Buy Signal — What Drove The Bullish Jump

Shares of TG Therapeutics experienced a significant increase on Wednesday following the announcement that their under-the-skin injection of Briumvi demonstrated safety comparable to the intravenous administration. This positive news resulted in an early buy signal for the biotech company, contributing to the bullish jump in the stock. The company's stock price surged by (mention percentage increase) as investors reacted to the encouraging development. The switch to a different route of administration for Briumvi could potentially lead to increased interest from investors and further growth opportunities for TG Therapeutics.

### Related Stocks

- [TGTX.US](https://longbridge.com/en/quote/TGTX.US.md)

## Related News & Research

- [BUZZ-TG Therapeutics rises on positive early data for subcutaneous multiple sclerosis drug](https://longbridge.com/en/news/288572596.md)
- [BUZZ-TG Therapeutics rises as early-stage data shows benefit in rare muscle weakness disease](https://longbridge.com/en/news/289184641.md)
- [TG Therapeutics Announces Positive Data From BRIUMVI Study, Initiates Phase 2 Trial; Stock Gains](https://longbridge.com/en/news/289203780.md)
- [TG Therapeutics Stock Is Surging Today: What's Driving The Action?](https://longbridge.com/en/news/289352299.md)
- [A Look At TG Therapeutics (TGTX) Valuation After Fresh BRIUMVI Clinical And Formulation Milestones](https://longbridge.com/en/news/289276120.md)